FDA’s first generic approvals slump 21% in 2024; Novartis’ top seller Entresto, cancer blockbuster Tasigna lead 2024 patent cliff

Data Compilation
#PharmaFlow

Pipeline Prospector Jan 2025: J&J’s US$ 14.6 bn Intra-Cellular buyout kicks off deal frenzy; Ozempic clinches FDA nod for CKD

Stock Recap
#PipelineProspector

Hibitane

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 28 USDMF, 9 CEP/COS, 8 JDMF, 7 EU WC, 1 VMF, 16 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

165 FDF Dossiers, 49 FDA Orange Book, 17 Europe, 68 Canada, 7 South Africa, 24 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;TOPICAL - 4%, SOLUTION;TOPICAL - 2%, TABLET;DENTAL - 2.5MG, SOLUTION;TOPICAL - 2%;70%, SPONGE;TOPICAL - 2%;70% (1.5ML), SPONGE;TOPICAL - 2%;70% (10.5ML), SPONGE;TOPICAL - 2%;70% (1ML), SPONGE;TOPICAL - 2%;70% (26ML), SPONGE;TOPICAL - 2%;70% (3ML), SOLUTION;TOPICAL - 61%;1%, SWAB;TOPICAL - 3.15%;70% (1.6ML), SWAB;TOPICAL - 3.15%;70% (1ML), SWAB;TOPICAL - 3.15%;70% (5.1ML), SWAB;TOPICAL - 2%;70% (0.67ML), SWAB;TOPICAL - 2%;70% (1.75ML), SWAB;TOPICAL - 2%;70% (5.25ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 5 Rochem International Inc, 4 SPI Pharma, 2 Seqens, 12 DKSH, 1 Pharm-RX Chemical, 1 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 4 ACG Worldwide, 18 Actylis, 1 Alcedo Pharmachem, 23 BASF, 2 BioSpectra, 1 Clariant, 6 Corel Pharma Chem, 4 Finar, 5 Gangwal Chemicals, 2 Ideal Cures Pvt Ltd, 9 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 1 Lubrizol Life Science Health, 3 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pluviaendo, 1 Qualicaps, 19 Roquette, 16 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

51 Topical, 34 Solubilizers, 31 Thickeners and Stabilizers, 31 Parenteral, 23 Coating Systems & Additives, 21 Fillers, Diluents & Binders, 19 Film Formers & Plasticizers, 11 Controlled & Modified Release, 11 Surfactant & Foaming Agents, 11 Rheology Modifiers, 10 Emulsifying Agents, 10 Co-Processed Excipients, 10 Taste Masking, 8 Empty Capsules, 5 Chewable & Orodispersible Aids, 5 Lubricants & Glidants, 5 Direct Compression, 4 API Stability Enhancers, 4 Granulation, 2 Disintegrants & Superdisintegrants, 1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 23 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 4 Finished Drug Prices

MARKET PLACE

32 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 1 US Exclusivities

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/01/2025	Evonik	Germany	EVONIK OPERATIONS GMBH Essen DE	R1-CEP 2001-343 - Rev 05	Chlorhexidine digluconate solution	2020-08-31	Valid	Chemical		658
28/01/2025	Medichem S.A	Spain	Medichem, S.A. Sant Joan Despí ES	R1-CEP 1993-009 - Rev 04	Chlorhexidine digluconate solution	2009-02-16	Valid	Chemical		658

Hibitane

Hibitane

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

48 API Suppliers

28 USDMF

9 CEP/COS

8 JDMF

7 EU WC

1 VMF

16 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

165 FDF Dossiers

49 FDA Orange Book

17 Europe

68 Canada

7 South Africa

24 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;TOPICAL - 4%

SOLUTION;TOPICAL - 2%

TABLET;DENTAL - 2.5MG

SOLUTION;TOPICAL - 2%;70%

SPONGE;TOPICAL - 2%;70% (1.5ML)

SPONGE;TOPICAL - 2%;70% (10.5ML)

SPONGE;TOPICAL - 2%;70% (1ML)

SPONGE;TOPICAL - 2%;70% (26ML)

SPONGE;TOPICAL - 2%;70% (3ML)

SOLUTION;TOPICAL - 61%;1%

SWAB;TOPICAL - 3.15%;70% (1.6ML)

SWAB;TOPICAL - 3.15%;70% (1ML)

SWAB;TOPICAL - 3.15%;70% (5.1ML)

SWAB;TOPICAL - 2%;70% (0.67ML)

SWAB;TOPICAL - 2%;70% (1.75ML)

SWAB;TOPICAL - 2%;70% (5.25ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI

5 Rochem International Inc

4 SPI Pharma

2 Seqens

12 DKSH

1 Pharm-RX Chemical

1 Faran Shimi Pharmaceutical

3 Boai NKY Pharmaceuticals Ltd

1 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

3 Pfanstiehl

4 ACG Worldwide

18 Actylis

1 Alcedo Pharmachem

23 BASF

2 BioSpectra

1 Clariant

6 Corel Pharma Chem

4 Finar

5 Gangwal Chemicals

2 Ideal Cures Pvt Ltd

9 Kerry

1 Kima Chemical

3 Lonza Capsugel

1 Lubrizol Life Science Health

3 Microlex e.U

1 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nomisma Healthcare

1 Novo Excipients

2 Pluviaendo

1 Qualicaps

19 Roquette

16 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries